CTMX Insider Trading

Insider Ownership Percentage: 7.00%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $122,204.29

CytomX Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at CytomX Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

CytomX Therapeutics Share Price & Price History

Current Price: $1.01
Price Change: Price Increase of +0.011 (1.10%)
As of 10/30/2024 12:55 PM ET

This chart shows the closing price history over time for CTMX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

CytomX Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/20/2024Christopher OgdenCFOSell1,984$1.23$2,440.32108,077View SEC Filing Icon  
8/20/2024Jeffrey B LandauInsiderSell4,181$1.23$5,142.63119,056View SEC Filing Icon  
8/20/2024Sean A. McCarthyCEOSell13,898$1.23$17,094.54657,851View SEC Filing Icon  
3/19/2024Christopher OgdenSVPSell2,971$2.09$6,209.3985,686View SEC Filing Icon  
3/19/2024Jeffrey B LandauInsiderSell6,562$2.09$13,714.58110,060View SEC Filing Icon  
3/19/2024Lloyd A RowlandGeneral CounselSell5,268$2.09$11,010.12117,728View SEC Filing Icon  
3/19/2024Sean A. McCarthyCEOSell20,223$2.09$42,266.07524,481View SEC Filing Icon  
12/20/2023Marcia BelvinSVPSell4,077$1.38$5,626.26155,124View SEC Filing Icon  
12/20/2023Sean A. McCarthyCEOSell13,551$1.38$18,700.38454,704View SEC Filing Icon  
9/22/2023Lloyd A RowlandGeneral CounselSell5,486$1.30$7,131.8080,609View SEC Filing Icon  
9/22/2023Marcia BelvinSVPSell4,119$1.30$5,354.70147,951View SEC Filing Icon  
9/22/2023Sean A. McCarthyCEOSell14,601$1.30$18,981.30430,755View SEC Filing Icon  
3/29/2023Elaine V JonesDirectorBuy5,000$1.55$7,750.005,142View SEC Filing Icon  
3/16/2023Amy C PetersonEVPSell4,257$1.98$8,428.8658,433View SEC Filing Icon  
3/16/2023Carlos CampoyCFOSell1,748$1.98$3,461.0438,224View SEC Filing Icon  
3/16/2023Christopher OgdenSVPSell516$1.98$1,021.6837,772View SEC Filing Icon  
3/16/2023Lloyd A RowlandGeneral CounselSell2,037$1.98$4,033.2671,095View SEC Filing Icon  
3/16/2023Sean A. McCarthyCEOSell7,121$1.88$13,387.48388,821View SEC Filing Icon  
7/20/2022Amy C PetersonEVPSell7,463$1.42$10,597.4662,690View SEC Filing Icon  
7/20/2022Carlos CampoyCFOSell3,949$1.42$5,607.5839,972View SEC Filing Icon  
7/20/2022Jeffrey B LandauInsiderSell4,206$1.42$5,972.5230,725View SEC Filing Icon  
7/20/2022Lloyd A RowlandGeneral CounselSell5,602$1.42$7,954.8443,689View SEC Filing Icon  
7/20/2022Sean A. McCarthyCEOSell14,911$1.42$21,173.62290,942View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for CytomX Therapeutics (NASDAQ:CTMX)

67.77% of CytomX Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CTMX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

CytomX Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
10/28/2024US Bancorp DE33,792$40K0.0%N/A0.043%Search for SEC Filing on Google Icon
10/23/2024Assenagon Asset Management S.A.1,644,168$1.94M0.0%+32.8%2.110%Search for SEC Filing on Google Icon
10/9/2024Congress Park Capital LLC1,216,008$1.44M0.5%+5.4%1.561%Search for SEC Filing on Google Icon
9/16/2024Cubist Systematic Strategies LLC82,054$100K0.0%+96.6%0.105%Search for SEC Filing on Google Icon
8/16/2024Forefront Analytics LLC64,065$78K0.0%+206.7%0.082%Search for SEC Filing on Google Icon
8/14/2024Squarepoint Ops LLC198,840$0.24M0.0%-22.7%0.255%Search for SEC Filing on Google Icon
8/14/2024Cubist Systematic Strategies LLC82,054$100K0.0%+96.6%0.105%Search for SEC Filing on Google Icon
8/13/2024Sei Investments Co.382,723$0.47M0.0%N/A0.491%Search for SEC Filing on Google Icon
8/12/2024XTX Topco Ltd60,586$74K0.0%+382.6%0.078%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC1,183,022$1.44M0.0%-4.0%1.518%Search for SEC Filing on Google Icon
8/6/2024Acadian Asset Management LLC2,728,569$3.32M0.0%+1.4%3.502%Search for SEC Filing on Google Icon
8/6/2024Candriam S.C.A.210,027$0.26M0.0%N/A0.270%Search for SEC Filing on Google Icon
7/18/2024Assenagon Asset Management S.A.1,238,499$1.51M0.0%+206.0%1.589%Search for SEC Filing on Google Icon
7/12/2024Congress Park Capital LLC1,153,220$1.41M0.6%+393.3%1.480%Search for SEC Filing on Google Icon
5/17/2024Tidal Investments LLC288,101$0.63M0.0%-5.9%0.370%Search for SEC Filing on Google Icon
5/16/2024Jacobs Levy Equity Management Inc.529,935$1.16M0.0%-33.0%0.680%Search for SEC Filing on Google Icon
5/10/2024Acadian Asset Management LLC2,690,830$5.86M0.0%+1.7%3.949%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.4,857,374$10.59M0.0%-0.9%7.129%Search for SEC Filing on Google Icon
5/7/2024Susquehanna Fundamental Investments LLC56,745$0.12M0.0%N/A0.083%Search for SEC Filing on Google Icon
5/7/2024SG Americas Securities LLC26,114$57K0.0%N/A0.038%Search for SEC Filing on Google Icon
4/16/2024Congress Park Capital LLC233,800$0.51M0.2%-2.3%0.345%Search for SEC Filing on Google Icon
2/15/2024Forefront Analytics LLC30,846$48K0.0%-37.6%0.046%Search for SEC Filing on Google Icon
2/7/2024Formidable Asset Management LLC306,107$0.47M0.1%-3.8%0.457%Search for SEC Filing on Google Icon
1/19/2024Congress Park Capital LLC239,300$0.37M0.2%+112.8%0.357%Search for SEC Filing on Google Icon
1/19/2024AlphaMark Advisors LLC23,183$36K0.0%+119.8%0.035%Search for SEC Filing on Google Icon
1/17/2024Assenagon Asset Management S.A.404,674$0.63M0.0%-5.0%0.604%Search for SEC Filing on Google Icon
11/13/2023Connor Clark & Lunn Investment Management Ltd.145,934$0.19M0.0%-6.5%0.218%Search for SEC Filing on Google Icon
11/6/2023Assenagon Asset Management S.A.425,921$0.55M0.0%-36.2%0.638%Search for SEC Filing on Google Icon
10/24/2023Bank of New York Mellon Corp266,836$0.34M0.0%+737.4%0.400%Search for SEC Filing on Google Icon
8/8/2023Bronte Capital Management Pty Ltd.925,245$1.59M0.2%+0.8%1.395%Search for SEC Filing on Google Icon
7/14/2023Congress Park Capital LLC106,150$0.18M0.1%+5.9%0.160%Search for SEC Filing on Google Icon
5/12/2023Tejara Capital Ltd157,928$0.24M0.1%-33.1%0.238%Search for SEC Filing on Google Icon
5/11/2023Cornercap Investment Counsel Inc.82,415$0.12M0.0%-44.4%0.124%Search for SEC Filing on Google Icon
5/10/2023Connor Clark & Lunn Investment Management Ltd.134,309$0.20M0.0%-11.1%0.202%Search for SEC Filing on Google Icon
5/1/2023Virtu Financial LLC24,136$36K0.0%N/A0.036%Search for SEC Filing on Google Icon
4/20/2023Congress Park Capital LLC100,200$0.15M0.1%N/A0.151%Search for SEC Filing on Google Icon
4/18/2023Assenagon Asset Management S.A.668,032$1.01M0.0%-27.0%1.009%Search for SEC Filing on Google Icon
2/15/2023Tang Capital Management LLC3,510,445$5.62M0.8%+0.3%5.312%Search for SEC Filing on Google Icon
2/13/2023Platinum Investment Management Ltd.635,798$1.02M0.0%-48.3%0.962%Search for SEC Filing on Google Icon
2/13/2023Forefront Analytics LLC24,787$40K0.0%-48.2%0.038%Search for SEC Filing on Google Icon
2/10/2023Connor Clark & Lunn Investment Management Ltd.151,020$0.24M0.0%-28.3%0.229%Search for SEC Filing on Google Icon
2/9/2023CM Management LLC75,000$0.12M0.1%N/A0.113%Search for SEC Filing on Google Icon
2/7/2023Commonwealth Equity Services LLC53,243$85K0.0%N/A0.081%Search for SEC Filing on Google Icon
2/7/2023Formidable Asset Management LLC318,233$0.51M0.1%+2.2%0.482%Search for SEC Filing on Google Icon
2/1/2023Bank of Montreal Can69,600$0.12M0.0%N/A0.105%Search for SEC Filing on Google Icon
1/12/2023Assenagon Asset Management S.A.914,900$1.46M0.0%-14.1%1.384%Search for SEC Filing on Google Icon
1/10/2023FNY Investment Advisers LLC65,000$0.10M0.1%N/A0.098%Search for SEC Filing on Google Icon
11/23/2022Toroso Investments LLC311,315$0.45M0.0%+49.8%0.471%Search for SEC Filing on Google Icon
11/15/2022Tang Capital Management LLC3,500,000$5.08M0.6%+231.9%5.296%Search for SEC Filing on Google Icon
11/15/2022Formidable Asset Management LLC311,315$0.45M0.1%+49.8%0.471%Search for SEC Filing on Google Icon
11/15/2022BVF Inc. IL6,595,801$9.56M0.4%+13.6%9.982%Search for SEC Filing on Google Icon
11/14/2022Ergoteles LLC279,056$0.41M0.0%-12.2%0.422%Search for SEC Filing on Google Icon
11/14/2022Forefront Analytics LLC47,869$71K0.0%+33.3%0.072%Search for SEC Filing on Google Icon
11/9/2022Magnus Financial Group LLC20,000$29K0.0%N/A0.030%Search for SEC Filing on Google Icon
11/8/2022AlphaCentric Advisors LLC257,500$0.37M0.4%N/A0.390%Search for SEC Filing on Google Icon
11/4/2022Russell Investments Group Ltd.61,320$88K0.0%-74.0%0.093%Search for SEC Filing on Google Icon
10/27/2022Assenagon Asset Management S.A.1,065,392$1.55M0.0%N/A1.615%Search for SEC Filing on Google Icon
8/16/2022Formidable Asset Management LLC207,772$0.38M0.1%N/A0.315%Search for SEC Filing on Google Icon
8/15/2022Clearline Capital LP196,583$0.36M0.0%+3.1%0.298%Search for SEC Filing on Google Icon
8/15/2022Point72 Asset Management L.P.2,750,000$5.03M0.0%-37.1%4.170%Search for SEC Filing on Google Icon
8/15/2022Laurion Capital Management LP1,270,900$2.33M0.0%N/A1.927%Search for SEC Filing on Google Icon
8/15/2022Knightsbridge Asset Management LLC96,926$0.18M0.0%N/A0.147%Search for SEC Filing on Google Icon
8/11/2022Platinum Investment Management Ltd.1,229,545$2.25M0.1%+25.5%1.864%Search for SEC Filing on Google Icon
8/10/2022Gladius Capital Management LP13,172$25K0.0%N/A0.020%Search for SEC Filing on Google Icon
8/10/2022Forefront Analytics LLC35,919$67K0.0%+145.3%0.054%Search for SEC Filing on Google Icon
8/9/2022Pictet Asset Management SA660,495$1.21M0.0%+87.0%1.002%Search for SEC Filing on Google Icon
8/5/2022Connor Clark & Lunn Investment Management Ltd.207,071$0.38M0.0%+3.4%0.317%Search for SEC Filing on Google Icon
7/29/2022Russell Investments Group Ltd.235,470$0.43M0.0%+175.8%0.360%Search for SEC Filing on Google Icon
5/17/2022RTW Investments LP5,779,700$15.43M0.3%-4.1%8.837%Search for SEC Filing on Google Icon
5/16/2022Clearline Capital LP190,600$0.51M0.1%+31.4%0.291%Search for SEC Filing on Google Icon
5/12/2022CI Investments Inc.60,992$0.16M0.0%N/A0.093%Search for SEC Filing on Google Icon
5/12/2022Acadian Asset Management LLC885,107$2.36M0.0%+115.2%1.353%Search for SEC Filing on Google Icon
5/12/2022Healthcare of Ontario Pension Plan Trust Fund1,290,600$3.45M0.0%N/A1.973%Search for SEC Filing on Google Icon
5/5/2022Russell Investments Group Ltd.85,379$0.23M0.0%-34.9%0.131%Search for SEC Filing on Google Icon
2/15/2022Rubric Capital Management LP2,406,449$10.42M0.5%N/A3.688%Search for SEC Filing on Google Icon
2/15/2022Sender Co & Partners Inc.40,720$0.18M0.1%N/A0.062%Search for SEC Filing on Google Icon
2/14/2022PDT Partners LLC135,123$0.59M0.0%+27.7%0.207%Search for SEC Filing on Google Icon
2/14/2022Clearline Capital LP145,000$0.63M0.1%N/A0.222%Search for SEC Filing on Google Icon
2/14/2022Altium Capital Management LP663,800$2.87M0.8%-46.2%1.017%Search for SEC Filing on Google Icon
2/10/2022Private Advisor Group LLC84,179$0.37M0.0%-32.3%0.129%Search for SEC Filing on Google Icon
2/10/2022Candriam Luxembourg S.C.A.1,760,922$7.62M0.0%-46.7%2.699%Search for SEC Filing on Google Icon
2/10/2022Pictet Asset Management SA288,326$1.25M0.0%N/A0.442%Search for SEC Filing on Google Icon
2/10/2022Rafferty Asset Management LLC152,369$0.66M0.0%-3.7%0.234%Search for SEC Filing on Google Icon
2/10/2022Acadian Asset Management LLC411,222$1.78M0.0%-41.3%0.630%Search for SEC Filing on Google Icon
2/10/2022Massachusetts Financial Services Co. MA357,134$1.55M0.0%-8.0%0.547%Search for SEC Filing on Google Icon
2/10/2022Connor Clark & Lunn Investment Management Ltd.201,758$0.87M0.0%+267.2%0.309%Search for SEC Filing on Google Icon
2/9/2022Principal Financial Group Inc.10,099$44K0.0%-60.6%0.015%Search for SEC Filing on Google Icon
2/9/2022Alps Advisors Inc.75,513$0.33M0.0%-5.4%0.116%Search for SEC Filing on Google Icon
2/9/2022Dimensional Fund Advisors LP522,027$2.26M0.0%+61.6%0.800%Search for SEC Filing on Google Icon
2/8/2022Raymond James Financial Services Advisors Inc.10,227$44K0.0%N/A0.016%Search for SEC Filing on Google Icon
2/8/2022Northern Trust Corp615,321$2.66M0.0%-6.0%0.943%Search for SEC Filing on Google Icon
2/7/2022SG Americas Securities LLC10,209$44K0.0%-66.9%0.016%Search for SEC Filing on Google Icon
1/28/2022Allspring Global Investments Holdings LLC90,846$0.39M0.0%N/A0.139%Search for SEC Filing on Google Icon
1/21/2022Clear Harbor Asset Management LLC11,440$50K0.0%N/A0.018%Search for SEC Filing on Google Icon
1/21/2022Russell Investments Group Ltd.131,051$0.57M0.0%-21.2%0.201%Search for SEC Filing on Google Icon
11/17/2021Altium Capital Management LP1,233,642$6.28M1.4%+43.0%1.891%Search for SEC Filing on Google Icon
11/16/2021Squarepoint Ops LLC39,718$0.20M0.0%-94.7%0.061%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Advisers LP201,200$1.02M0.0%-45.5%0.308%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Investments LP101,854$0.52M0.0%+20.8%0.156%Search for SEC Filing on Google Icon
11/16/2021Metropolitan Life Insurance Co NY6,646$34K0.0%-64.9%0.010%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
CytomX Therapeutics logo
CytomX Therapeutics, Inc., an oncology-focused biopharmaceutical company, focuses on developing novel conditionally activated biologics localized to the tumor microenvironment. The company utilizes conditional activation platform technology for oncology biologics research and development comprising the validation of targets for antibody-drug conjugates (ADCs), opening therapeutic window for novel T-cell engagers (TCEs) targeting solid tumors, and increasing the therapeutic index for immune modulators, such as cytokines; and PROBODY platform in preclinical research in areas outside of oncology. It also develops CX-904, a T-cell-engaging bispecific antibody targeting the epidermal growth factor receptor (EGFR) on tumor cells and the CD3 receptor on T cells; CX-2051, a conditionally activated ADC for optimizing the therapeutic index for EpCAM-expressing epithelial cancers, including colorectal cancer; and CX-801, an interferon alpha-2b PROBODY cytokine. In addition, the company's development pipeline comprises CX-2029, a conditional activated ADC targeting CD71; and BMS-986288, a PROBODY version of non-fucosylated ipilimumab. It has strategic collaborations with Amgen, Astellas, Bristol Myers Squibb, Regeneron, and Moderna. CytomX Therapeutics, Inc. was founded in 2008 and is headquartered in South San Francisco, California.
Read More on CytomX Therapeutics

Today's Range

Now: $1.01
Low: $0.99
High: $1.03

50 Day Range

MA: $1.17
Low: $1.00
High: $1.31

52 Week Range

Now: $1.01
Low: $0.99
High: $5.85

Volume

152,721 shs

Average Volume

2,603,589 shs

Market Capitalization

$78.70 million

P/E Ratio

7.21

Dividend Yield

N/A

Beta

1.04

Who are the company insiders with the largest holdings of CytomX Therapeutics?

CytomX Therapeutics' top insider investors include:
  1. Sean A Mccarthy (CEO)
  2. Marcia Belvin (SVP)
  3. Jeffrey B Landau (Insider)
  4. Lloyd A Rowland (General Counsel)
  5. Christopher Ogden (CFO)
  6. Christopher Ogden (SVP)
  7. Amy C Peterson (EVP)
  8. Carlos Campoy (CFO)
  9. Elaine V Jones (Director)
Learn More about top insider investors at CytomX Therapeutics.

Who are the major institutional investors of CytomX Therapeutics?

CytomX Therapeutics' top institutional investors include:
  1. Assenagon Asset Management S.A. — 2.11%
  2. Congress Park Capital LLC — 1.56%
  3. US Bancorp DE — 0.04%
Learn More about top institutional investors of CytomX Therapeutics stock.

Which institutional investors are buying CytomX Therapeutics stock?

Within the previous quarter, CTMX stock was bought by institutional investors including:
  1. Assenagon Asset Management S.A.
  2. Congress Park Capital LLC
  3. US Bancorp DE